SXSW 2024
CancerX in 2050: The Digitization of Cancer Research & Care
Description:
In March 2024, CancerX celebrates its impactful first year—a public-private partnership announced by The White House, boosting cancer innovation through the national accelerator, aligning with the reignited Cancer Moonshot.
Join our session to hear about the second-year priorities and expect riveting discussions on three pivotal initiatives: pre-competitive evidence generation, a catalyst for groundbreaking research; the Accelerator, driving collaboration and swift progress; and the transformative Demonstration Projects, furthering research and implementations of innovations in cancer care
Related Media
Other Resources / Information
Takeaways
- Outline findings from the progress made in pre-competitive evidence-generation projects
- Spotlight innovations and share progress from the first CancerX accelerator cohort
- Announce updates on the first demonstration project of CancerX
Speakers
- Stephen Konya, Senior Advisor to the Deputy National Coordinator for Health IT and Innovation Portfolio Lead, U.S. Department of Health and Human Services (HHS) l
- Jennifer Goldsack, CEO, Digital Medicine Society
- Edmondo Robinson, SVP and Chief Digital Officer, Moffitt Cancer Center
Organizer
Smit Patel, Associate Program Director And Executive Lead, Digital Medicine Society
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments